
Cabozantinib S-malat
Cabozantinib S-malat se yon inibitè efikas milti reseptè tirozin kinaz ak valè IC5 0 nan 0.035, 1.3, 4.6, 7, ak 11.3 nM, respektivman, pou anpeche VEGFR2, c-Met, Kit, Axl, ak Flt3.
NO CAS:1140909-48-3
Fòmil molekilè: C ∝₂ H ∝₀ FN ∝ O ₁₀
Pwa molekilè: 635.6
Purity:>98%
lòt non: Cabozantinib S-malat|1140909-48-3|Cabozantinib malat|cabozantinib (S)-malat|Cabometyx|Cabozantinib malat (XL184)|Cabozantinib (S-malat)|XL184|Cometriq|UNII-DR7ST46X58|BMS907351|Cabozantinib s-malat [USAN]|cabozantinib L-malat|DR7ST46X58|CHEBI:72319
Dekri teren
|
Non API |
Nimewo CAS |
Estrikti |
Estati |
|
Cabozantinib S-malat
|
1140909-48-3
|
|
Komèsyal |
Cabozantinib S-malat
NO CAS:1140909-48-3
Fòmil molekilè: C ∝₂ H ∝₀ FN ∝ O ₁₀
Pwa molekilè: 635.6
Purity:>98%
Cabozantinib S-malat|1140909-48-3|Cabozantinib malat|Cabozantinib (S) - malat|Cabometyx|Cabozantinib malat (XL184)|Cabozantinib (S-malat)|XL184|Cometriq|UNII-DR7ST46X58|BMS907351|Cabozantinib s-malat [USAN]|Cabozantinib L-malat|DR7ST46X58|CHEBI: 72319
Spesifikasyon oswa pite Pi gran pase oswa egal a 99%
Non angle Cabozantinib malate (XL184)
Mekanis byochimik Cabozantinib S malat (XL184 BMS 907351) se yon inibitè VEGFR2 ki pisan ak IC50 nan 0.035 nM epi tou inibitè c-Met, Ret, Kit, Flt-1/3/4, Tie2, ak AXL ak IC50 nan 1.3 nM, 4 nM, 4.6 nM, 12 nM/11.3 nM/6 nM, 14.3 nM ak 7 nM, respektivman
Tanperati depo -20 degre C
Kondisyon transpò: ultra-ba tanperati transpò glas pake
Kalite inibitè aksyon
Mekanis aksyon: inibitè reseptè faktè kwasans epatosit
Cabozantinib malat se malat nan Cabozantinib, yon inibitè VEGFR2 ki pisan ak IC50 nan 0.035 nM epi tou li anpeche c-Met, Ret, Kit, Flt-1/3/4, Tie2, ak AXL ak IC50. nan 1.3 nM, 4 nM, 4.6 nM, 12 nM/11.3 nM/6 nM, 14.3 nM ak 7 nM, respektivman
Cabozantinib S-malat se yon inibitè efikas milti reseptè tirozin kinaz ak valè IC5 0 nan 0.035, 1.3, 4.6, 7, ak 11.3 nM, respektivman, pou anpeche VEGFR2, c-Met, Kit, Axl, ak Flt3.
Pwovizyon pou ak Espesifikasyon
Espesifikasyon miltip ki disponib ak yon gwo kantite ka Customized;
Baj popilè: cabozantinib s-malat, Lachin cabozantinib s-malate manifaktirè, Swèd, faktori
Voye rechèch
Ou ka renmen tou






